Abbott India Fact Sheet, Abbott India Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Abbott India Fact Sheet    (KNOL)


LIVE NOW: Join Our Urgent Broadcast on India's Revival with Tanushree Banerjee


Here is the latest financial fact sheet of Abbott India. For more details, see the Abbott India quarterly results and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.

ABBOTT INDIA Price History

Price Rs 21,189.2
Mkt Cap Rs m 450,255
Vol '000 0.5
P/E X 63.8
P/CF X 60.1
EPS (TTM) Rs 332.3
% ch % -1.9
No. of shares m 21.25
% ch week % 1.0
% ch 1-mth % 12.0
% ch 12-mth % 32.5
52 week H/L Rs 21,850.0/13,970.1
(As on Sep 24, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ABBOTT INDIA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ABBOTT INDIA EQUITY SHARE DATA
High Rs5,1906,1108,83416,86918,569 
Low Rs4,3513,9965,4587,15013,970 
Sales per share (Unadj.) Rs1,348.91,548.21,731.11,926.22,028.2 
Earnings per share (Unadj.) Rs130.2188.8211.9279.0325.0 
Diluted earnings per shareRs130.2188.8211.9279.0325.0 
Cash flow per share (Unadj.) Rs137.9196.4219.9307.1352.4 
Dividends per share (Unadj.) Rs40.0055.0065.00250.00275.00 
Adj. dividends per shareRs40.0055.0065.00250.01275.01 
Avg Dividend yield %0.81.10.92.11.7 
Book value per share (Unadj.) Rs646.4786.7932.21,127.51,203.7 
Adj. book value per shareRs646.4786.8932.21,127.51,203.8 
Shares outstanding (eoy) m21.2521.2521.2521.2521.25 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x3.53.34.16.28.0 
Avg P/E ratio x36.626.833.743.050.1 
P/CF ratio (eoy) x34.625.732.539.146.2 
Price / Book Value ratio x7.46.47.710.713.5 
Dividend payout %30.729.130.789.684.6 
Avg Mkt Cap Rs m101,370107,372151,843255,193345,717 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,4533,9374,3564,7614,927 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ABBOTT INDIA INCOME DATA
Net Sales Rs m28,66432,89936,78640,93143,100 
Other income Rs m6021,1811,1401,147835 
Total revenues Rs m29,26634,08037,92642,07843,935 
Gross profit Rs m3,9485,2346,0407,5629,189 
Depreciation Rs m164162169596581 
Interest Rs m20382285183 
Profit before tax Rs m4,3656,2156,9898,0279,260 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,5982,2032,4852,0982,353 
Profit after tax Rs m2,7664,0124,5035,9296,907 
Gross profit margin %13.815.916.418.521.3 
Effective tax rate %36.635.435.626.125.4 
Net profit margin %9.712.212.214.516.0 
ABBOTT INDIA BALANCE SHEET DATA
Current assets Rs m18,93022,65527,61032,04735,185 
Current liabilities Rs m6,3166,6818,5698,91110,309 
Net working cap to sales %44.048.651.856.557.7 
Current ratio x3.03.43.23.63.4 
Inventory Days Days66654 
Debtors Days Days22292732 
Net fixed assets Rs m1,6041,3611,6693,2783,041 
Share capital Rs m212212212213213 
"Free" reserves Rs m13,52416,50619,59623,74725,366 
Net worth Rs m13,73616,71819,80823,95925,579 
Long term debt Rs m00000 
Total assets Rs m20,53424,01629,27835,32438,226 
Interest coverage x215.3163.6311.995.151.7 
Debt to equity ratio x00000 
Sales to assets ratio x1.41.41.31.21.1 
Return on assets %13.616.915.517.018.5 
Return on equity %20.124.022.724.727.0 
Return on capital %31.937.435.433.936.9 
Exports to sales %0.50.70.50.30.7 
Imports to sales %13.111.013.112.712.3 
Exports (fob) Rs m155239180118295 
Imports (cif) Rs m3,7413,6344,8195,1955,306 
Fx inflow Rs m228369369332353 
Fx outflow Rs m3,8293,8074,9185,2815,389 
Net fx Rs m-3,601-3,438-4,549-4,949-5,035 
ABBOTT INDIA CASH FLOW
From Operations Rs m 3,072 1,527 4,991 6,261 7,267 
From Investments Rs m -1,554 -2,148 -2,570 -4,012 -718 
From Financial Activity Rs m -898 -1,024 -1,428 -2,168 -5,818 
Net Cashflow Rs m 620 -1,646 993 81 731 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 75.0%
Institution 7.0%
Non-Institution 18.0%
Total 100.0%
Free Float 25.0%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Unit No. 3, Corporate Park, Sion Trombay Road, Mumbai - 400071
E-MAIL webmasterindia@abbott.com/investorrelations.india@abbott.com WEB www.abbott.co.in
TEL 022-50461000/2000/1119/1117/1116/6797 8888 FAX 022-5016 9400
SECTOR PHARMACEUTICALS GROUP Abbott India - MNC
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
AUDITOR Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 1.3

Read: ABBOTT INDIA 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   PATIDAR BUILDCON  MOREPEN LABS  HESTER BIOSCIENCES  SHALBY   MERCURY LAB.  

Compare ABBOTT INDIA With:   PATIDAR BUILDCON  MOREPEN LABS  HESTER BIOSCIENCES  SHALBY   MERCURY LAB.  




Today's Market

Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

ALKEM LABORATORIES at All Time High; BSE HEALTHCARE Index Down 1.4% (Market Updates)

Sep 24, 2021 | Updated on Sep 24, 2021

ALKEM LABORATORIES share price has hit an all time high at Rs 4,068 (up 1.7%). The BSE HEALTHCARE Index is down by 1.4%. Among the top gainers in the BSE HEALTHCARE Index today are ALKEM LABORATORIES (up 1.7%) and PROCTER & GAMBLE HEALTH (up 0.3%). The top losers include SUN PHARMA ADV. RES. and BLISS GVS PHARMA (down 0.1%).

ABBOTT INDIA Announces Quarterly Results (1QFY22); Net Profit Up 8.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 8.5% YoY). Sales on the other hand came in at Rs 12 bn (up 14.4% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of ABBOTT INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ABBOTT INDIA. Also includes updates on the valuation of ABBOTT INDIA.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield (Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC (Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

India's Most Trusted Corporate Group is... (Views On News)

Sep 11, 2021

We conducted a poll of 17 of the most popular corporate groups in India. With an overwhelming response from 5,274 participants, here is what we found.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA - ZIM LABORATORIES COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS